Metoprolol kinetics and dose response in hypertensive patients
暂无分享,去创建一个
[1] Grant R. Wilkinson,et al. A physiological approach to hepatic drug clearance , 1975 .
[2] E. Frohlich,et al. Immediate Hemodynamic Effects of Beta‐Adrenergic Blockade with Propranolol in Normotensive and Hypertensive Man , 1968, Circulation.
[3] C. L. Jones,et al. Rapid GLC determination of propranolol in human plasma samples. , 1977, Journal of pharmaceutical sciences.
[4] D. Shand,et al. Plasma binding and the affinity of propranolol for a beta receptor in man , 1976, Clinical pharmacology and therapeutics.
[5] T. Walle,et al. The predictable relationship between plasma levels and dose during chronic propranolol therapy , 1978, Clinical pharmacology and therapeutics.
[6] C. von Bahr,et al. Plasma levels and effects of metoprolol on blood pressure, adrenergic beta receptor blockade, and plasma renin activity in essential hypertension , 1976, Clinical pharmacology and therapeutics.
[7] C. Dollery,et al. Brain concentration of propranolol in relation to hypotensive effect in the rabbit with observations on brain propranolol levels in man. , 1975, The Journal of pharmacology and experimental therapeutics.
[8] D. Shand,et al. The hemodynamic effects of beta adrenergic blockade on the flow-dependent hepatic clearance of propranolol. , 1973, The Journal of pharmacology and experimental therapeutics.
[9] J. Parker,et al. Propranolol in the Treatment of Angina Pectoris: Comparison of Duration of Action in Acute and Sustained Oral Therapy , 1979, Circulation.
[10] P. R. Reid,et al. Lidocaine kinetics predicted by indocyanine green clearance. , 1978, The New England journal of medicine.
[11] C. Regårdh,et al. Comparative bioavailability and effect studies on metoprolol administered as ordinary and slow-release tablets in single and multiple doses. , 2009, Acta pharmacologica et toxicologica.
[12] C. Regårdh,et al. Plasma levels and effects of metoprolol on blood pressure and heart rate in hypertensive patients after an acute dose and between two doses during long‐term treatment , 1975, Clinical pharmacology and therapeutics.
[13] D. Shand,et al. Disposition of propranolol V. Drug accumulation and steady‐state concentrations during chronic oral administration in man , 1973, Clinical pharmacology and therapeutics.
[14] C. Dollery,et al. Atenolol in essential hypertension , 1976, Clinical pharmacology and therapeutics.